跳至主要内容
临床试验/EUCTR2007-002713-39-DK
EUCTR2007-002713-39-DK进行中(未招募)不适用

Quality of life related to recombinant TSH treatment compared to no treatment related to iodine uptake, in patient with thyroid cancer.A double blinded, randomized crossover study.Dathyrca I

dept of endocrinology J 106, herlev Hosptial0 个研究点目标入组 100 人开始时间: 2007年7月24日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients, surgery treated for thyroid cancer, follicular og papillary.
  • age 18-75yaer
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • <18 year old
  • >75 year old
  • pregnant or lactating women
  • persons not able to give informed consent

研究者

发起方
dept of endocrinology J 106, herlev Hosptial

相似试验